Xiong A, Li W, Li X, Fan Y, et al. Efficacy and safety of KN046, a novel bispecific antibody against PD-L1 and CTLA-4, in patients with non-small cell lung cancer who failed platinum-based chemotherapy: a phase II study. Eur J Cancer 2023;190:112936.
PMID: 37393762